The nurse is planning to administer sucralfate to a client with peptic ulcer disease. Which action should the nurse indude in this patient's plan of care?

A. Affirm the decision to use the medication when the symptoms start to worsen: Waiting to start rivastigmine until symptoms worsen may not be the best approach, as early intervention can be more beneficial in managing symptoms and slowing disease progression.
B. Assess the client’s current mental status before deciding to support the decision: While assessing the client's mental status is important, the immediate concern is to educate on the timing of medication use rather than evaluating the current state of the client.
C. Confirm that the daughter is aware of the progressive nature of the disease: It is important for the daughter to understand the progressive nature of Alzheimer's disease, but this does not directly address the timing for starting rivastigmine.
D. Explain that the drug should be used early in the course of the disease process: Rivastigmine, a cholinesterase inhibitor, is most effective when started early in the course of Alzheimer's disease. Early use can help manage symptoms more effectively and potentially delay progression.

A) Administer the scheduled dose: Administering the scheduled dose of warfarin when the INR is 5.0 is not appropriate because this INR level is significantly elevated, indicating a high risk of bleeding. Warfarin dosing should be adjusted based on INR levels to prevent complications such as excessive bleeding.
B) Discontinue the warfarin schedule: Completely discontinuing warfarin may not be necessary unless there are additional factors or signs of bleeding. It is essential to take appropriate action based on the INR level, but discontinuation should be guided by further evaluation and healthcare provider recommendations.
C) Withhold warfarin for 24 hours: Withholding the dose of warfarin is the correct action when faced with an elevated INR of 5.0. This intervention is crucial to prevent potential bleeding complications while waiting for further evaluation and guidance from the healthcare provider regarding additional management, such as administration of vitamin K or other reversal agents.

D) Obtain another INR analysis immediately: While obtaining another INR analysis can be helpful in monitoring trends, it is not the immediate priority if the INR is already 5.0. The primary action should be to withhold the dose and consult with the healthcare provider to determine the appropriate next steps for managing the elevated INR and ensuring patient safety.